Altered balance between excitatory and inhibitory inputs onto CA1 pyramidal neurons from SV2A-deficient but not SV2B-deficient mice

Journal of Neuroscience Research

Volumn 90, Issue 12, 2012, Pages 2317-2327

  Venkatesan, Kumar ^a   Alix, Philippe ^a   Marquet, Alice ^a   Doupagne, Melissa ^a   Niespodziany, Isabelle ^c   Rogister, Bernard ^a,b   Seutin, Vincent ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b UNIVERSITY OF LIÈGE   (Belgium)

^c UCB PHARMA   (Belgium)

Author keywords

CA1; Double knockout mice; Excitatory postsynaptic currents; Inhibitory postsynaptic currents; SV2

Indexed keywords

4 AMINOBUTYRATE AMINOTRANSFERASE; GLUTAMIC ACID; GLYCOPROTEIN; SYNAPTIC VESICLE PROTEIN 2A; SYNAPTIC VESICLE PROTEIN 2B; SYNAPTIC VESICLE PROTEIN 2C; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; EXCITATORY POSTSYNAPTIC POTENTIAL; GENOTYPE; HIPPOCAMPAL CA1 REGION; HIPPOCAMPAL CA3 REGION; INHIBITORY POSTSYNAPTIC POTENTIAL; KNOCKOUT MOUSE; MOUSE; NERVE EXCITABILITY; NONHUMAN; PATCH CLAMP; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; SEIZURE; TRANSGENIC MOUSE; WEIGHT REDUCTION; WILD TYPE;

ACTION POTENTIALS; ANIMALS; CA1 REGION, HIPPOCAMPAL; CALCIUM SIGNALING; EXCITATORY POSTSYNAPTIC POTENTIALS; GENES, LETHAL; GLUTAMIC ACID; INHIBITORY POSTSYNAPTIC POTENTIALS; MEMBRANE GLYCOPROTEINS; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; NERVE TISSUE PROTEINS; PATCH-CLAMP TECHNIQUES; PROTEIN ISOFORMS; PYRAMIDAL CELLS; SYNAPTIC VESICLES;

EID: 84867743271     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.23111     Document Type: Article

References (49)

1. Bai D, Zhu G, Pennefather P, Jackson MF, MacDonald JF, Orser BA. 2001. Distinct functional and pharmacological properties of tonic and quantal inhibitory postsynaptic currents mediated by gamma-aminobutyric acid (A) receptors in hippocampal neurons. Mol Pharmacol 59: 814-824.
2. Bajjalieh SM, Peterson K, Shinghal R, Scheller RH. 1992. SV2, a brain synaptic vesicle protein homologous to bacterial transporters. Science 257: 1271-1273.
3. Bajjalieh SM, Peterson K, Linial M, Scheller RH. 1993. Brain contains two forms of synaptic vesicle protein 2. Proc Natl Acad Sci U S A 90: 2150-2154.
4. Bajjalieh SM, Frantz GD, Weimann JM, McConnell SK, Scheller RH. 1994. Differential expression of synaptic vesicle protein 2 (SV2) isoforms. J Neurosci 14: 5223-5235.
5. Ben-Ari Y. 1985. Limbic seizure and brain damage produced by kainic acid: mechanisms and relevance to human temporal lobe epilepsy. Neurosci 14: 375-403.
6. Bennett B, Matagne A, Michel P, Leonard M, Cornet M, Meeus MA, Toublanc N. 2007. Seletracetam (UCB 44212). Neurotherapeutics 4: 117-122.
7. Buckley K, Kelly RB. 1985. Identification of a transmembrane glycoprotein specific for secretory vesicles of neural and endocrine cells. J Cell Biol 100: 1284-1294.
8. Budzinski KL, Allen RW, Fujimoto BS, Kensel-Hammes P, Belnap DM, Bajjalieh SM, Chiu DT. 2009. Large structural change in isolated synaptic vesicles upon loading with neurotransmitter. Biophys J 97: 2577-2584.
9. Caraiscos VB, Elliott EM, You-Ten KE, Cheng VY, Belelli D, Newell JG, Jackson MF, Lambert JJ, Rosahl TW, Wafford KA, MacDonald JF, Orser BA. 2004. Tonic inhibition in mouse hippocampal CA1 pyramidal neurons is mediated by alpha5 subunit-containing gamma-aminobutyric acid type A receptors. Proc Natl Acad Sci U S A 101: 3662-3667.
10. 2+-induced exocytosis. J Neurosci 29: 883-897.
11. Cobos I, Calcagnotto ME, Vilaythong AJ, Thwin MT, Noebels JL, Baraban SC, Rubenstein JL. 2005. Mice lacking Dlx1 show subtype-specific loss of interneurons, reduced inhibition, and epilepsy. Nat Neurosci 8: 1059-1068.
12. Cohen AS, Lin DD, Coulter DA. 2000. Protracted postnatal development of inhibitory synaptic transmission in rat hippocampal area CA1 neurons. J Neurophysiol 84: 2465-2476.
13. Crowder KM, Gunther JM, Jones TA, Hale BD, Zhang H-Z, Peterson MR, Scheller RH, Chavkin C, Bajjalieh SM. 1999. Abnormal neurotransmission in mice lacking synaptic vesicle protein 2A (SV2A) Proc Natl Acad Sci U S A 96: 115268-115273.
14. Custer KL, Austin NS, Sullivan JM, Bajjalieh SM. 2006. Synaptic vesicle protein 2 enhances release probability at quiescent synapses. J Neurosci 26: 1303-1313.
15. de Lanerolle NC, Kim JH, Robbins RJ, Spencer DD. 1989. Hippocampal interneuron loss and plasticity in human temporal lobe epilepsy. Brain Res 495: 387-395.
16. Dudek FE, Spitz M. 1997. Hypothetical mechanisms for the cellular and neurophysiologic basis of secondary epileptogenesis: proposed role of synaptic reorganization. J Clin. Neurophysiol 14: 90-101.
17. During MJ, Spencer DD. 1993. Extracellular hippocampal glutamate and spontaneous seizure in the conscious human brain. Lancet 341: 1607-1610.
18. Farrant M, Nusser Z. 2005. Variations on an inhibitory theme: phasic and tonic activation of GABA(A) receptors. Nat Rev Neurosci 6: 215-229.
19. Fatt P, Katz B. 1952. Spontaneous subthreshold activity at motor nerve endings. J Physiol 117: 109-128.
20. Fernandez-Chacon R, Konigstorfer A, Gerber SH, Garcia J, Matos MF, Stevens CF, Brose N, Rizo J, Rosenmund C, Sudhof TC. 2001. Synaptotagmin I functions as a calcium regulator of release probability. Nature 410: 41-49.
21. 2+ sensor for transmitter release at a central synapse. Cell 79: 717-727.
22. Gillard M, Chatelain P, Fuks B. 2006. Binding characteristics of levetiracetam to synaptic vesicle protein 2A (SV2A) in human brain and in CHO cells expressing the human recombinant protein. Eur J Pharmacol 536: 102-108.
23. Haas HL, Rose G. 1982. Long-term potentiation of excitatory synaptic transmission in the rat hippocampus: the role of inhibitory processes. JPhysiol 329: 541-552.
24. Jacobs KM, Prince DA. 2005. Excitatory and inhibitory postsynaptic currents in a rat model of epileptogenic microgyria. J Neurophysiol 93: 687-696.
25. Janz R, Sudhof TC. 1999. SV2C is a synaptic vesicle protein with an unusually restricted localization: anatomy of a synaptic vesicle protein family. Neuroscience 94: 1279-1290.
26. 2+ regulators in neurotransmitter release. Neuron 24: 1003-1016.
27. Jonas P, Major G, Sakmann B. 1993. Quantal components of unitary EPSCs at the mossy fibre synapse on CA3 pyramidal cells of rat hippocampus. J Physiol 472: 615-663.
28. Kaminski RM, Matagne A, Leclercq K, Gillard M, Michel P, Kenda B, Talaga P, Klitgaard H. 2008. SV2A protein is a broad-spectrum anticonvulsant target: functional correlation between protein binding and seizure protection in models of both partial and generalized epilepsy. Neuropharmacology 54: 715-720.
29. Kaminski RM, Gillard M, Leclercq K, Hanon E, Lorent G, Dassesse D, Matagne A, Klitgaard H. 2009. Proepileptic phenotype of SV2A-deficient mice is associated with reduced anticonvulsant efficacy of levetiracetam. Epilepsia 50: 1729-1740.
30. Kaminski RM, Fu Z, Venkatesan K, Mazzuferi M, Leclercq K, Seutin V, Vicini S. 2011. 11-Deoxycortisol impedes GABAergic neurotransmission and induces drug-resistant status epilepticus in mice. Neuropharmacology 60: 1098-1108.
31. Kobayashi M, Buckmaster PS. 2003. Reduced inhibition of dentate granule cells in a model of temporal lobe epilepsy. J Neurosci 23: 2440-2452.
32. Lowe AW, Madeddu L, Kelly RB. 1988. Endocrine secretory granules and neuronal synaptic vesicles have three integral membrane proteins in common. J Cell Biol 106: 51-59.
33. Lu YM, Mansuy IM, Kandel ER, Roder J. 2000. Calcineurin-mediated LTD of GABAergic inhibition underlies the increased excitability of CA1 neurons associated with LTP. Neuron 26: 197-205.
34. Lynch BA, Lambeng N, Nocka K, Kensel-Hammes P, Bajjalieh SM, Matagne A, Fuks B. 2004. The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam. Proc Natl Acad Sci U S A 101: 9861-9866.
35. Matveeva EA, Vanaman TC, Whiteheart SW, Slevin JT. 2007. Asymmetric accumulation of hippocampal 7S SNARE complexes occurs regardless of kindling paradigm. Epilepsy Res 73: 266-274.
36. McNamara JO. 1999. Emerging insights into the genesis of epilepsy. Nature 399( 6738 Suppl): A15-A22.
37. Meldrum BS. 1994. The role of glutamate in epilepsy and other CNS disorders. Neurology 44: S14-S23.
38. Otis TS, Staley KJ, Mody I. 1991. Perpetual inhibitory activity in mammalian brain slices generated by spontaneous GABA release. Brain Res 545: 142-150.
39. Sara Y, Virmani T, Deak F, Liu X, Kavalali ET. 2005. An isolated pool of vesicles recycles at rest and drives spontaneous neurotransmission. Neuron 45: 563-573.
40. Schivell AE, Mochida S, Kensel-Hammes P, Custer KL, Bajjalieh SM. 2005. SV2A and SV2C contain a unique synaptotagmin-binding site. Mol Cell Neurosci 29: 56-64.
41. Sperk G, Furtinger S, Schwarzer C, Pirker S. 2004. GABA and its receptors in epilepsy. Adv Exp Med Biol 548: 92-103.
42. Storm-Mathisen J, Ottersen OP. 1989. Anatomy of putative glutamatergic neurons. In: Avoli M, Reader TA, Dykes RW, Gloor P, editors. Neurotransmitters and cortical function. London: Plenum Press. p 39-70.
43. 2+-sensor model for neurotransmitter release in a central synapse. Nature 450: 676-682.
44. Sutton MA, Wall NR, Aakalu GN, Schuman EM. 2004. Regulation of dendritic protein synthesis by miniature synaptic events. Science 304: 1979-1983.
45. Sutton MA, Taylor AM, Ito HT, Pham A, Schuman EM. 2007. Postsynaptic decoding of neural activity: eEF2 as a biochemical sensor coupling miniature synaptic transmission to local protein synthesis. Neuron 55: 648-661.
46. van Vliet EA, Aronica E, Redeker S, Boer K, Gorter JA. 2008. Decreased expression of synaptic vesicle protein 2A, the binding site for levetiracetam, during epileptogenesis and chronic epilepsy. Epilepsia 50: 422-433.
47. Wasser CR, Kavalali ET. 2009. Leaky synapses: regulation of spontaneous neurotransmission in central synapses. Neuroscience 158: 177-188.
48. Xiang H, Chen HX, Yu XX, King MA, Roper SN. 2006. Reduced excitatory drive in interneurons in an animal model of cortical dysplasia. J Neurophysiol 96: 569-578.
49. Xu T, Bajjalieh SM. 2001. SV2 modulates the size of the readily releasable pool of secretory vesicles. Nat Cell Biol 3: 691-698.